These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 22503878

  • 1. Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacin.
    Delattre IK, Musuamba FT, Jacqmin P, Taccone FS, Laterre PF, Verbeeck RK, Jacobs F, Wallemacq P.
    Clin Biochem; 2012 Jul; 45(10-11):780-6. PubMed ID: 22503878
    [Abstract] [Full Text] [Related]

  • 2. Empirical models for dosage optimization of four beta-lactams in critically ill septic patients based on therapeutic drug monitoring of amikacin.
    Delattre IK, Musuamba FT, Verbeeck RK, Dugernier T, Spapen H, Laterre PF, Wittebole X, Cumps J, Taccone FS, Vincent JL, Jacobs F, Wallemacq PE.
    Clin Biochem; 2010 Apr; 43(6):589-98. PubMed ID: 20036226
    [Abstract] [Full Text] [Related]

  • 3. Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients.
    Delattre IK, Musuamba FT, Nyberg J, Taccone FS, Laterre PF, Verbeeck RK, Jacobs F, Wallemacq PE.
    Ther Drug Monit; 2010 Dec; 32(6):749-56. PubMed ID: 20962708
    [Abstract] [Full Text] [Related]

  • 4. Case-control study of drug monitoring of β-lactams in obese critically ill patients.
    Hites M, Taccone FS, Wolff F, Cotton F, Beumier M, De Backer D, Roisin S, Lorent S, Surin R, Seyler L, Vincent JL, Jacobs F.
    Antimicrob Agents Chemother; 2013 Feb; 57(2):708-15. PubMed ID: 23147743
    [Abstract] [Full Text] [Related]

  • 5. Can changes in renal function predict variations in β-lactam concentrations in septic patients?
    Casu GS, Hites M, Jacobs F, Cotton F, Wolff F, Beumier M, De Backer D, Vincent JL, Taccone FS.
    Int J Antimicrob Agents; 2013 Nov; 42(5):422-8. PubMed ID: 23993066
    [Abstract] [Full Text] [Related]

  • 6. Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams.
    Gonçalves-Pereira J, Póvoa P.
    Crit Care; 2011 Nov; 15(5):R206. PubMed ID: 21914174
    [Abstract] [Full Text] [Related]

  • 7. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.
    Taccone FS, Laterre PF, Dugernier T, Spapen H, Delattre I, Wittebole X, De Backer D, Layeux B, Wallemacq P, Vincent JL, Jacobs F.
    Crit Care; 2010 Nov; 14(4):R126. PubMed ID: 20594297
    [Abstract] [Full Text] [Related]

  • 8. Rapid quantification of six β-lactams to optimize dosage regimens in severely septic patients.
    Wolff F, Deprez G, Seyler L, Taccone F, Hites M, Gulbis B, Vincent JL, Jacobs F, Cotton F.
    Talanta; 2013 Jan 15; 103():153-60. PubMed ID: 23200371
    [Abstract] [Full Text] [Related]

  • 9. β-Lactam Dosage Regimens in Septic Patients with Augmented Renal Clearance.
    Jacobs A, Taccone FS, Roberts JA, Jacobs F, Cotton F, Wolff F, Creteur J, Vincent JL, Hites M.
    Antimicrob Agents Chemother; 2018 Sep 15; 62(9):. PubMed ID: 29987138
    [Abstract] [Full Text] [Related]

  • 10. β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia.
    Hayashi Y, Lipman J, Udy AA, Ng M, McWhinney B, Ungerer J, Lust K, Roberts JA.
    Int J Antimicrob Agents; 2013 Feb 15; 41(2):162-6. PubMed ID: 23153962
    [Abstract] [Full Text] [Related]

  • 11. Serum β-lactam concentrations in critically ill patients with cirrhosis: a matched case-control study.
    Lheureux O, Trepo E, Hites M, Cotton F, Wolff F, Surin R, Creteur J, Vincent JL, Gustot T, Jacobs F, Taccone FS.
    Liver Int; 2016 Jul 15; 36(7):1002-10. PubMed ID: 26645828
    [Abstract] [Full Text] [Related]

  • 12. Covariate determinants of effective dosing regimens for time-dependent beta-lactam antibiotics for critically ill patients.
    Kaska M, Havel E, Selke-Krulichova I, Safranek P, Bezouska J, Martinkova J.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Sep 15; 162(3):219-226. PubMed ID: 29582860
    [Abstract] [Full Text] [Related]

  • 13. Influence of sepsis on higher daily dose of amikacin pharmacokinetics in critically ill patients.
    Mahmoudi L, Mohammadpour AH, Ahmadi A, Niknam R, Mojtahedzadeh M.
    Eur Rev Med Pharmacol Sci; 2013 Feb 15; 17(3):285-91. PubMed ID: 23426530
    [Abstract] [Full Text] [Related]

  • 14. Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy.
    Seyler L, Cotton F, Taccone FS, De Backer D, Macours P, Vincent JL, Jacobs F.
    Crit Care; 2011 Feb 15; 15(3):R137. PubMed ID: 21649882
    [Abstract] [Full Text] [Related]

  • 15. β-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case-control study.
    Donadello K, Antonucci E, Cristallini S, Roberts JA, Beumier M, Scolletta S, Jacobs F, Rondelet B, de Backer D, Vincent JL, Taccone FS.
    Int J Antimicrob Agents; 2015 Mar 15; 45(3):278-82. PubMed ID: 25542059
    [Abstract] [Full Text] [Related]

  • 16. Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?
    Roberts JA, Roberts MS, Robertson TA, Dalley AJ, Lipman J.
    Crit Care Med; 2009 Mar 15; 37(3):926-33. PubMed ID: 19237898
    [Abstract] [Full Text] [Related]

  • 17. β-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review.
    Sinnollareddy MG, Roberts MS, Lipman J, Roberts JA.
    Clin Exp Pharmacol Physiol; 2012 Jun 15; 39(6):489-96. PubMed ID: 22519600
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic variability of beta-lactams in critically ill patients: A narrative review.
    Boidin C, Moshiri P, Dahyot-Fizelier C, Goutelle S, Lefeuvre S.
    Anaesth Crit Care Pain Med; 2020 Feb 15; 39(1):87-109. PubMed ID: 31513935
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of meropenem in critically ill patients with severe infections.
    Binder L, Schwörer H, Hoppe S, Streit F, Neumann S, Beckmann A, Wachter R, Oellerich M, Walson PD.
    Ther Drug Monit; 2013 Feb 15; 35(1):63-70. PubMed ID: 23318279
    [Abstract] [Full Text] [Related]

  • 20. Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of β-lactams administered by continuous infusion: a prospective observational study.
    Carrié C, Petit L, d'Houdain N, Sauvage N, Cottenceau V, Lafitte M, Foumenteze C, Hisz Q, Menu D, Legeron R, Breilh D, Sztark F.
    Int J Antimicrob Agents; 2018 Mar 15; 51(3):443-449. PubMed ID: 29180280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.